Tildrakizumab-asmn Subcutaneous and Tri Femynor
Determining the interaction of Tildrakizumab-asmn Subcutaneous and Tri Femynor and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
Generic Name: ethinyl estradiol / norgestimate
Brand name: Estarylla, Femynor, Mili, Mono-Linyah, Mononessa, Ortho-Cyclen, Tri-Lo-Marzia>
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tildrakizumab-asmn Subcutaneous-Tri Vites with Fluoride and Iron
- Tildrakizumab-asmn Subcutaneous-Tri-Estarylla
- Tildrakizumab-asmn Subcutaneous-Tri-Legest
- Tildrakizumab-asmn Subcutaneous-Tri-Legest Fe
- Tildrakizumab-asmn Subcutaneous-Tri-Linyah
- Tildrakizumab-asmn Subcutaneous-Tri-Lo-Estarylla
- Tri Femynor-Tilia Fe
- Tri Femynor-Tiludronate
- Tri Femynor-Timentin
- Tri Femynor-Timentin Add-Vantage
- Tri Femynor-Timentin Injection
- Tri Femynor-Timentin Novaplus